Tectonic Therapeutic (TECX) Profit After Tax (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Profit After Tax of -$25.2 million for Q1 2026, down 58.69% year-over-year from -$61.1 million in Q1 2025, and down 30.95% quarter-over-quarter from -$19.3 million in Q4 2025.
Tectonic Therapeutic (TECX) Profit After Tax (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Profit After Tax for 10 consecutive years, with -$25.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 58.69% year-over-year to -$25.2 million; the TTM figure through Mar 2026 stood at -$83.5 million (down 42.34% YoY), while the FY2025 annual figure was -$74.2 million, down 27.93% from the prior year.
- Profit After Tax eased to -$25.2 million in Q1 2026 per TECX's latest filing, from -$19.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$7.8 million in Q4 2023 and bottomed at -$29.8 million in Q1 2022.
- Historically, Profit After Tax has averaged -$18.0 million across 5 years, with a median of -$17.7 million in 2024.
- Annual changes were most pronounced in 2023 — Profit After Tax surged 68.66% — and 2024, when it plunged 76.22%.
- Tectonic Therapeutic's Profit After Tax stood at -$25.0 million in 2022, then soared by 68.66% to -$7.8 million in 2023, then plunged by 57.93% to -$12.4 million in 2024, then slumped by 55.56% to -$19.3 million in 2025, then tumbled by 30.95% to -$25.2 million in 2026.
- Business Quant data shows TECX's Profit After Tax at -$25.2 million in Q1 2026, -$19.3 million in Q4 2025, and -$19.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | -22.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.30 Mn |
| Mar 31, 2026 | -25.24 Mn |
| Dec 31, 2025 | -19.28 Mn |
| Sep 30, 2025 | -19.04 Mn |
| Jun 30, 2025 | -19.98 Mn |
| Mar 31, 2025 | -15.91 Mn |
| Dec 31, 2024 | -12.39 Mn |
| Sep 30, 2024 | -17.72 Mn |
| Jun 30, 2024 | -12.67 Mn |
| Mar 31, 2024 | -15.22 Mn |
| Dec 31, 2023 | -7.85 Mn |
| Sep 30, 2023 | -10.05 Mn |
| Jun 30, 2023 | -10.46 Mn |
| Mar 31, 2023 | -14.45 Mn |
| Dec 31, 2022 | -25.03 Mn |
| Sep 30, 2022 | -22.97 Mn |
| Jun 30, 2022 | -28.05 Mn |
| Mar 31, 2022 | -29.83 Mn |
| Dec 31, 2021 | -28.23 Mn |
| Sep 30, 2021 | -32.61 Mn |